PMID: 2507000Aug 12, 1989Paper

Passive smoking and cardiorespiratory health in a general population in the west of Scotland

BMJ : British Medical Journal
D J HoleV M Hawthorne

Abstract

OBJECTIVE-To assess the risk of cardiorespiratory symptoms and mortality in non-smokers who were passively exposed to environmental smoke. Prospective study of cohort from general population first screened between 1972 and 1976 and followed up for an average of 11.5 years, with linkage of data from participants in the same household. Renfrew and Paisely, adjacent burghs in urban west Scotland. 15,399 Men and women (80% of all those aged 45-64 resident in Renfrew or Paisley) comprised the original cohort; 7997 attended for multiphasic screening with a cohabitee. Passive smoking and control groups were defined on the basis of a lifelong non-smoking index case and whether the cohabitee had ever smoked or never smoked. Cardiorespiratory signs and symptoms and mortality. Each of the cardiorespiratory symptoms examined produced relative risks greater than 1.0 (though none were significant) for passive smokers compared with controls. Adjusted forced expiratory volume in one second was significantly lower in passive smokers than controls. All cause mortality was higher in passive smokers than controls (rate ratio 1.27 (95% confidence interval 0.95 to 1.70)), as were all causes of death related to smoking (rate ratio 1.30 (0.91 to 1.85]...Continue Reading

References

Nov 8, 1986·British Medical Journal·N J WaldH S Cuckle
Nov 1, 1987·American Journal of Epidemiology·K H SvendsenJ K Ockene
May 1, 1985·American Journal of Epidemiology·C GarlandD L Wingard
Sep 7, 1974·British Medical Journal·V M HawthorneD G Beevers
Jan 1, 1972·International Journal of Epidemiology·V M HawthorneD S Maclean
Mar 27, 1980·The New England Journal of Medicine·J R White, H F Froeb

❮ Previous
Next ❯

Citations

Aug 1, 1994·Journal of the American College of Cardiology·A J Wells
Mar 1, 1995·Journal of Clinical Epidemiology·M S JaakkolaP Ernst
Apr 7, 2004·Preventive Medicine·Robert J MoffattBryant A Stamford
Mar 1, 1996·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·R L TweedieK L Mengersen
Feb 15, 2000·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·L ZhongJ A Hanley
Jan 13, 1998·Journal of the American College of Cardiology·A J Wells
May 20, 2003·Respirology : Official Journal of the Asian Pacific Society of Respirology·Moira Chan-Yeung, Helen Dimich-Ward
Mar 25, 1999·The New England Journal of Medicine·J HeP K Whelton
Mar 1, 1992·Archives of Environmental Health·R J Shephard
Aug 11, 2007·International Journal of Epidemiology·Richard TaylorAnnette Dobson
Oct 17, 1998·Journal of the National Cancer Institute·P BoffettaR Saracci
Sep 13, 2012·Cardiology in Review·Andrew DunbarWilliam Frishman
Dec 24, 1997·Clinical and Experimental Pharmacology & Physiology·T H Lam, Y He
Sep 16, 1989·BMJ : British Medical Journal·P N Lee
Oct 28, 1989·BMJ : British Medical Journal·D J HoleV M Hawthorne
Jan 13, 1990·BMJ : British Medical Journal·P N Lee
Dec 15, 1990·BMJ : British Medical Journal·R Beaglehole
Mar 14, 1992·BMJ : British Medical Journal·J M WhiteC P Farrington
Jun 5, 1993·BMJ : British Medical Journal·H De Vos IrvineC R Gillis
Oct 12, 1996·BMJ : British Medical Journal·G D Smith, A N Phillips
Apr 7, 2004·BMJ : British Medical Journal·Sarah HillAlistair Woodward
Jul 2, 2004·BMJ : British Medical Journal·Peter H WhincupDerek G Cook
Aug 21, 2001·Occupational and Environmental Medicine·R ChenR Tavendale
Jan 1, 1997·Annual Review of Public Health·R C BrownsonK E Warner
Jan 1, 2002·Tobacco Induced Diseases·D GuptaSk Jindal
Dec 11, 1999·Environmental Health Perspectives·K G Brown
Nov 1, 1992·American Journal of Public Health·R C BrownsonT S Loy
Aug 23, 2001·Journal of Occupational and Environmental Medicine·M M Nurminen, M S Jaakkola
Jan 1, 1991·Journal of Toxicology. Clinical Toxicology·B O BrooksR D Schimke
Apr 18, 2009·American Journal of Preventive Medicine·Jenine K HarrisSarah C Shelton
Jun 24, 2008·Immunology and Allergy Clinics of North America·Mark D Eisner
Feb 16, 2007·Annals of Epidemiology·Mark D EisnerIra B Tager

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.